IgD ligation allows peritoneal cavity B cell proliferation

Area of Science:

• Immunology
• Tumor Microenvironment Research

Background:

• Tumor microenvironments (TMEs) are characterized by atypical cytokine production and immune cell imbalances, notably high macrophage proportions.
• Peritoneal cavity (PerC) cells, with their high macrophage-to-lymphocyte ratio, serve as a model for TMEs.
• Macrophages typically inhibit lymphocyte proliferation upon T cell receptor (TCR) or B cell receptor (BCR) ligation, though PHA and anti-CD40 stimulation can induce proliferation.

Purpose of the Study:

• To investigate novel activators of peritoneal cavity (PerC) B and T cells within a macrophage-rich model.
• To explore the differential effects of IgD and IgM ligation on PerC B cell proliferation.
• To assess the impact of IL-4 and concurrent IgD/CD3 ligation on PerC immune cell responses.

Main Methods:

• Culturing peritoneal cavity (PerC) cells from mice.
• Stimulating PerC cells with IgD, IgM, PHA, anti-CD40, and IL-4.
• Analyzing T cell receptor (TCR) and B cell receptor (BCR) ligation effects.
• Investigating the synergistic effect of IgD and CD3 ligation on T cell proliferation.

Main Results:

• IgD ligation, in contrast to IgM, specifically triggers peritoneal cavity (PerC) B cell proliferation.
• Interleukin-4 (IL-4) enhanced IgD-induced B cell responses in BALB/c mice but suppressed them in C57BL/6 mice.
• Concurrent ligation of IgD and CD3 epsilon (CD3ε) restored T cell proliferative capacity in PerC cultures.

Conclusions:

• IgD acts as a novel activator for peritoneal cavity (PerC) B cells.
• The response to IgD ligation is strain-dependent and modulated by IL-4.
• Combined IgD and CD3 ligation can overcome macrophage-mediated suppression of T cell proliferation.
• These findings identify new targets for enhancing cellular and humoral immunity in models of macrophage-rich tumor microenvironments (TMEs).